The UK leaving the EU is not the end of cooperation. Talks are ongoing to determine how the two will work together on anything from trade to transport and the fight against crime.
The EU and the UK face many of the same challenges such as climate change and police cooperation and have much to gain from working together on these issues.
The Withdrawal Agreement, which has been ratified by both parties, covers the protection of the rights of EU citizens in the UK and UK citizens living in other parts of the EU, the UK’s financial commitments undertaken as a member state, as well border issues (especially between the UK and the Republic of Ireland) and this needs to be implemented in full.
Future relations will be part of a separate agreement, which is currently being negotiated on the basis of the political declaration that was approved and ratified by both parties.
In a resolution adopted on 12 February, MEPs called for a comprehensive agreement that includes a level playing field to be guaranteed through robust commitments and an agreement on fisheries.
On 29 May, David McAllister, chair of Parliament’s UK Coordination Group, said in a statement: “Parliament will not consent to an agreement that does not include provisions on level playing field, fundamental rights, robust governance and a stable framework for fisheries.
“It also considers the full implementation of the Withdrawal Agreement, co-signed by the UK Prime Minister, to be crucial.”
Members of the foreign affairs and trade committees reiterated their overwhelming support for the EU position in the talks between the EU and the UK on their future relationship on 12 June. All MEPs will vote on the draft resolution during the plenary session on 17-19 June.
The committee votes came ahead of a conference on the ongoing talks on 15 June with UK Prime Minister Boris Johnson, European Council President Charles Michel and Commission President Ursula Von der Leyen and the participation of Parliament President David Sassoli. After the conference, they issued a joint statement.
What the future relations agreement will cover
The issues in any agreement on future relations range from the exchange of goods and services to the environment, research, education and so on.
One of the key negotiations will concern the conditions and principles for future trade, including the questions of possible tariffs, product standards, a level-playing field, fisheries, the respect of fundamental rights and how to resolve disputes.
Citizens’ rights are protected by the withdrawal agreement. EU citizens in the UK and Brits in the EU have the right to continue living and working where they are now. This topic will remain a key concern for the European Parliament, for example regarding freedom of movement and health coverage for EU citizens in the UK. MEPs are following closely how the withdrawal agreement is being implemented.
Under the withdrawal agreement, there is a transition period until the end of December 2020. During the transition period, the UK has access to the single market and is subject to EU legislation, although it is no longer be able to shape new EU laws.
The aim is to conclude talks before the end of the transition period. The transition period can be extended upon request once, but the decision to do so must be taken before 1 July.
If no agreement is reached by the end of the transition period, the UK will trade with the EU under World Trade Organization rules.
How the negotiations work
Former commissioner Michel Barnier leads the negotiations on behalf of the EU, based on political guidelines issued by the European Council. Barnier also led negotiations on the withdrawal agreement.
MEPs are able to influence negotiations by adopting resolutions setting out the Parliament’s position. Parliament set up a UK contact group, led by German EPP member David McAllister, who is the chair of the foreign affairs committee, to liaise with EU negotiator Barnier and coordinate with parliamentary committees that are involved.
Any agreement can only enter into force if it is approved by the European Parliament and the Council. Unlike the withdrawal agreement, it is also possible that the agreement on future relations will also have to be approved by national parliaments if it refers to competences the EU shares with member states. It will also need to be approved by the UK.
Coronavirus: Commission unveils EU vaccines strategy
Today, to help protect people everywhere, the European Commission is presenting a European strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. An effective and safe vaccine against the virus is our best bet to achieve a permanent solution to the pandemic. Time is of the essence. Every month gained in finding such a vaccine saves lives, livelihoods and billions of euros. Today’s strategy proposes a joint EU approach and builds on the mandate received from EU health ministers.
European Commission President Ursula von der Leyen said: “This is a moment for science and solidarity. Nothing is certain, but I am confident that we can mobilise the resources to find a vaccine to beat this virus once and for all. We must be ready to manufacture and deploy such a vaccine across Europe and the world. This vaccine will be a breakthrough in the fight against the coronavirus, and a testament to what partners can achieve when we put our minds, research and resources together. The European Union will do all in its power to ensure that all peoples of this world have access to a vaccine, irrespective of where they live.”
Commissioner for Health and Food Safety Stella Kyriakides said: “Working together will increase our chances of securing access to a safe and effective vaccine at the scale we need and as quickly as possible. It will ensure fair and equitable access for all across the EU and globally, thus offering the best opportunity of finding a permanent exit strategy from the COVID-19 crisis. This is the EU at its best: pooling resources, joining efforts, bringing tangible results to the everyday lives of people. No one is safe until everyone is safe and we will leave no stones unturned in our efforts to protect EU and global citizens.”
Vaccine development is a complex and lengthy process. With today’s strategy, the Commission will support efforts to accelerate the development and availability of safe and effective vaccines in a timeframe between 12 and 18 months, if not earlier. Delivering on this complex undertaking requires running clinical trials in parallel with investing in production capacity to be able to produce millions, or even billions, of doses of a successful vaccine. The Commission is fully mobilised to support the efforts of vaccine developers in their endeavour.
This is not a European challenge, but a global one. The European Union will not be safe until the entire world has access to a vaccine, and as such, the EU and its Member States have both a responsibility and an interest to make a vaccine universally available.
An important step towards joint action between Member States has already been taken in the formation of an inclusive vaccine Alliance by France, Germany, Italy, and the Netherlands. The EU Vaccine Strategy will implement a joint approach going forward.
The strategy has the following objectives:
- Ensuring the quality, safety and efficacy of vaccines.
- Securing swift access to vaccines for Member States and their populations while leading the global solidarity effort.
- Ensuring equitable access to an affordable vaccine as early as possible.
The EU strategy rests on two pillars:
- Securing the production of vaccines in the EU and sufficient supplies for its Member States through Advance Purchase Agreements with vaccine producers via the Emergency Support Instrument. Additional financing and other forms of support can be made available on top of such agreements.
- Adapting the EU’s regulatory framework to the current urgency and making use of existing regulatory flexibility to accelerate the development, authorisation and availability of vaccines while maintaining the standards for vaccine quality, safety and efficacy.
Advance Purchase Agreements
In order to support companies in the swift development and production of a vaccine, the Commission will enter into agreements with individual vaccine producers on behalf of the Member States. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission will finance part of the upfront costs faced by vaccines producers. This will take the form of Advance Purchase Agreements. Funding provided will be considered as a down-payment on the vaccines that will actually be purchased by Member States.
The related funding will come from a significant part of the €2.7 billion Emergency Support Instrument. Additional support will be available through loans from the European Investment Bank.
When taking the financing decision on what vaccines to support, the following non-exhaustive criteria will be taken into account, including: soundness of scientific approach and technology used, speed of delivery at scale, cost, risk sharing, liability, coverage of different technologies, early engagement with EU regulators, global solidarity, and capacity to supply through development of production capacity within the EU.
There is always a risk that supported candidates fail during clinical trials. This Strategy is therefore similar to an insurance policy, by transferring some of the risks from industry to public authorities in return for assuring Member States of equitable and affordable access to a vaccine, should one become available.
A flexible and robust regulatory process
Regulatory processes will be flexible but remain robust. Together with the Member States and the European Medicines Agency, the Commission will make the greatest use of existing flexibilities in the EU’s regulatory framework to accelerate the authorisation and availability of successful vaccines against COVID-19. This includes an accelerated procedure for authorisation, flexibility in relation to labelling and packaging, and a proposal to provide temporary derogations from certain provisions of the GMO legislation to speed up clinical trials of COVID-19 vaccines and medicines containing genetically modified organisms.
The EU is contributing to the global effort for universal testing, treatment and vaccination by mobilising resources through international pledging and by joining forces with countries and global health organisations through the Access To Covid-19 Tools (ACT) Accelerator collaborative framework. The Global Coronavirus Response pledging campaign raised €9.8 billion by the end of May 2020. A second step is underway in partnership with Global Citizen and other governmental and non-governmental partners, culminating in a global pledging summit on 27 June.
The European Commission is committed to the principle of universal, equitable and affordable access to vaccines, especially for the most vulnerable countries. It is ready to explore with international partners if a significant number of countries would agree to pool resources for jointly reserving future vaccines from companies for themselves as well as for low and middle-income countries at the same time. The high-income countries could act as an inclusive international buyers’ group, thus accelerating the development of safe and effective vaccines and maximise access to them for all who need it across the world.
EU clears way for the EU Digital COVID Certificate
Today, the Presidents of the three EU institutions, the European Parliament, the Council of the EU and the European Commission attended the official signing ceremony for the Regulation on the EU Digital COVID Certificate, marking the end of the legislative process. On this occasion Presidents David Sassoli and Ursula von der Leyen and Prime Minister António Costa said:
“The EU Digital COVID Certificate is a symbol of what Europe stands for. Of a Europe that does not falter when put to the test. A Europe that unites and grows when faced with challenges. Our Union showed again that we work best when we work together. The EU Digital COVID Certificate Regulation was agreed between our institutions in the record time of 62 days. While we worked through the legislative process, we also built the technical backbone of the system, the EU gateway, which is live since 1 June.
We can be proud of this great achievement. The Europe that we all know and that we all want back is a Europe without barriers. The EU Certificate will again enable citizens to enjoy this most tangible and cherished of EU rights – the right to free movement. Signed into law today, it will enable us to travel more safely this summer. Today we reaffirm together that an open Europe prevails.”
EU Digital COVID Certificate
The aim of the EU Digital COVID Certificate is to facilitate safe and free movement inside the EU during the COVID-19 pandemic. All Europeans have the right to free movement, also without the certificate, but the certificate will facilitate travel, exempting holders from restrictions like quarantine.
The EU Digital COVID Certificate will be accessible for everyone and it will:
- cover COVID-19 vaccination, test and recovery;
- be free of charge and available in all EU languages;
- be available in a digital and paper-based format;
- be secure and include a digitally signed QR code;
Member States shall refrain from imposing additional travel restrictions on the holders of an EU Digital COVID Certificate, unless they are necessary and proportionate to safeguard public health.
In addition, the Commission committed to mobilising €100 million under the Emergency Support Instrument to support Member States in providing affordable tests.
The Regulation will apply for 12 months as of 1 July 2021.
On 17 March 2021, the European Commission presented a proposal to create an EU COVID Certificate to facilitate the safe free movement of citizens within the EU during the pandemic. On 20 May, co-legislators reached a provisional agreement. On 1 June, the technical backbone of the systems, the EU gateway, went live. The gateway allows the verification of the security features contained in the QR codes.
Following the official signature today, the Regulation will enter into application on 1 July, with a phasing-in period of six weeks for the issuance of certificates for those Member States that need additional time.
13 Member States have already started to issue EU Digital COVID Certificates.
EU proposes a strong multilateral trade response to the COVID-19 pandemic
EU has submitted its proposal seeking the commitment of World Trade Organization (WTO) members for a multilateral trade action plan to expand the production of COVID-19 vaccines and treatments, and ensure universal and fair access. With this proposal to the WTO, divided in two communications, the EU underlines the WTO’s central role in the response to the COVID-19 pandemic and urges fellow WTO members to agree on a set of commitments, including on intellectual property rights.
President von der Leyen said: “The EU has actively shown solidarity with the world since the beginning of the pandemic. The European Union authorized exports of around half of the total amount of vaccines produced in Europe. Our immediate, urgent goal is to ensure equitable access for low – and middle-income countries, to share vaccines wider and faster. And we continue to help ramping up production. The EU proposes concrete short and medium term solutions to ensure universal access at affordable prices. I am looking forward to discuss with the G7 leaders next week how to achieve this goal. Beyond the current crisis, it is important to ensure global preparedness for future pandemics: diversifying manufacturing so that it is not centralised only in a handful of countries and strengthening the resilience of the healthcare infrastructure in least developed countries”.
Executive Vice-President and Commissioner for Trade Valdis Dombrovskis said: “The pandemic is still with us and there can be no room for complacency. We need to urgently concentrate on proposals that accelerate the equitable distribution of COVID-19 vaccines worldwide. In this respect, a strong multilateral trade response could deliver a huge boost in the fight against COVID-19. In reality, the main problem at this moment relates to the lack of sufficient manufacturing capacity to rapidly produce the required quantities. The objective must be to ensure that any available and adequate manufacturing capacity anywhere in the world is used for the COVID-19 vaccines production.”
More on the EU’s proposal
The EU calls on governments to:
- Ensure that COVID-19 vaccines, treatments and their components can cross borders freely;
- encourage producers to expand their production, while ensuring that those countries most in need of vaccines receive them at an affordable price, and;
- facilitate the use of compulsory licensing within the WTO’s existing Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The TRIPS Agreement already provides this flexibility, which is a legitimate tool during the pandemic that can be used swiftly where needed
The first element aims to limit the use of export restrictions and keep supply chains open. Vaccine-producing countries should be ready to export a fair share of their domestic production. Supply chains are highly interconnected and should not be disrupted. In addition, the EU considers that supplies to the COVAX Facility should never be restricted, and no measures should limit trade in inputs necessary for the production of COVID-19 vaccines and treatments.
The second element calls on governments to strongly encourage and support vaccine manufacturers and developers to expand production and ensure the affordable supply of vaccines to low- and middle-income countries. Such actions could include licensing agreements, the sharing of expertise, tiered pricing including non-profit sales to low-income countries, contract manufacturing and new investments in manufacturing facilities in developing countries. The EU expects all vaccine producers and developers to make concrete pledges that increase supplies to vulnerable developing countries. In this regard, the EU welcomes the commitment of companies such as BioNTech and Pfizer, Johnson & Johnson and Moderna, which have already committed to delivering 1.3 billion doses this year to low-income countries at no profit and to middle-income countries at lower cost.
The third element, on intellectual property, sets out that voluntary licences are the most effective instrument to facilitate the expansion of production and sharing of expertise. Where voluntary cooperation fails, compulsory licences, whereby a government grants a targeted licence allowing a willing producer to make a vaccine without the consent of a patent holder, are a legitimate tool in the context of a pandemic. The EU considers that all WTO members should be ready to:
- agree that the COVID-19 pandemic is an exceptional circumstance of national emergency, and that the requirement to negotiate with the rights’ holder may be legitimately waived where needed;
- support manufacturers that are ready to produce vaccines and/or treatments at affordable prices under a compulsory licence so that the level of remuneration paid by the manufacturer to the patent holder reflects such affordable prices;
- agree that the compulsory licence could cover any exports destined to countries that lack manufacturing capacity, including via the COVAX facility.
The EU is also tabling a dedicated communication on intellectual property to the WTO body in charge of implementing the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Council). Here, the EU provides more detail and clarity on each of the three points on intellectual property and links them with the specific provisions in the TRIPS Agreement. As regards the broad waiver proposed by a number of WTO members, the European Commission, while ready to discuss any option that helps end the pandemic as soon as possible, is not convinced that this would provide the best immediate response to reach the objective of the widest and timely distribution of COVID-19 vaccines that the world urgently needs. Today’s proposals aim at achieving that objective in a swift and effective manner.
EU Digital COVID Certificate: Parliament and Council reach agreement
The Commission welcomes today’s provisional political agreement between the European Parliament and the Council on the Regulation governing the EU Digital COVID Certificate. This means that the certificate (previously called the Digital Green Certificate) is well on track to be ready end of June, as planned. Today’s agreement has been reached in record time just two months after the Commission’s proposal. The negotiations on the certificate for the Commission have been led by Commissioner Didier Reynders in close cooperation with Vice-Presidents Vera Jourová and Margaritis Schinas and Commissioners Thierry Breton, Stella Kyriakides, and Ylva Johansson.
Welcoming this swift progress, President Ursula von der Leyen said:
“We are delivering on our commitment to have the EU Digital COVID Certificate up and running before the summer. European citizens are looking forward to travelling again, and today’s agreement means they will be able to do so safely very soon.
The EU Digital COVID Certificate is free of charge, secure and accessible to all. It will cover vaccination, test and recovery offering different options to the citizens. It fully respects citizens’ fundamental rights, including protection of personal data.
All EU citizens have a fundamental right to free movement in the EU. The EU Digital COVID Certificate, available in paper or digital format, will make it easier for Europeans to travel – whether to see their families and loved ones or to get some well-deserved rest.
We would like to thank the European Parliament and the Portuguese Presidency for their dedication, perseverance and immense work at record speed to find an agreement on the proposal we presented.
Work still remains. At EU level, the system will be ready in the next few days. It is now crucial that all Member States press ahead with the roll-out of their national systems to ensure that the system can be up and running as soon as possible. This is what EU citizens rightly expect.
Today’s agreement has demonstrated that with the commitment and cooperation of all, the EU Digital COVID Certificate will be available on time.”
The EU Digital COVID Certificate – key features
Following the agreement reached by the European Parliament and the Council, the EU Digital COVID Certificate:
- will cover vaccination, test and recovery;
- will be available in a digital and paper-based format, depending on the choice of the recipients, and contain a digitally signed QR code;
- will be free of charge, be obtained easily and also available to persons vaccinated before the EU Digital COVID Certificate Regulation has entered into force;
- may also be used by Member States for national purposes, if this is provided for in national law.
- Member States shall refrain from imposing additional travel restrictions on the holders of an EU Digital COVID Certificate, unless they are necessary and proportionate to safeguard public health.
- The Commission will also mobilise €100 million to support Member States in providing affordable tests.
The political agreement will now have to be formally adopted by the European Parliament and the Council. The Regulation will enter into force on 1 July, with a phasing-in period of six weeks for the issuance of certificates for those Member States that need additional time.
In parallel, the Commission will continue to support the Member States in finalising their national solutions for the issuance and verification of EU Digital COVID Certificate, and to provide technical and financial support to Member States to on-board the gateway.
On 17 March 2021, the European Commission presented a proposal to create an EU COVID certificate to facilitate the safe free movement of citizens within the EU during the COVID-19 pandemic. At the Commission’s request, the Parliament voted in favour of the activation of the urgent procedure for the two proposals on 25 March. The Council adopted its negotiating position on 14 April, and the Parliament did so on 29 April. On 20 May co-legislators reached provisional agreement on this file.
In parallel to the legislative process, important progress was already made on the technical side. The EU Gateway, which allows to verify certificates across borders, is ready and will go live as of June. Successful pilot tests took place with 17 Member States and Iceland during the last two weeks, further five Member States will test next week.
The Commission also provide open source reference software to support Member States to develop their national solution to issue certificates, to scan and check the QR codes, and a reference wallet for storage.
Previously, on 21 April, technical specification guidelines were adopted by Member States representatives in the eHealth Network, a voluntary network connecting national authorities responsible for eHealth. They are building on the close work of the Commission with the Member States, having resulted in first guidelines adopted in January and updated on 12 March, and a trust framework outline agreed on 12 March 2021. In addition, a common design template was developed in the eHealth network.
A beginner’s guide to sustainable farming
Industrialized farming has been a reliable way to produce lots of food at a relatively low cost. But it’s not...
Afghanistan Will Test SCO’s Capacity
The US is withdrawing from Afghanistan. Twenty years of the US-led foreign intervention has brought neither prosperity, nor stability, to...
Turkish Airlines and Turkish Cargo Rise to the Top Amid Pandemic
Turkish Airlines successfully ended the fiscal year 2020 with 6.7 billion USD revenue, which accounts for 50% of the preceding...
Fragile Stabilisation of Confrontation
Prospects for relations between Russia and the United States after the summit in Geneva The Russia-US summit in Geneva will...
The Private And Public Joe Biden: Belief And Policy
Joe Biden supports abortion rights politically, a position conflicting with doctrine in the Catholic church. Despite the pope issuing a...
Is Covid-19 Zoonotic, Natural or Lab-engineered?
President Trump led the US government propaganda that Coronavirus originated in WIV. However, even after twelve months the US government...
Will U.S. Sanctions Against Ethiopia Provide Russia with Regional Opening?
The U.S. has recently imposed sanctions against some Ethiopian officials who Washington blames for alleged human rights abuses in the...
Defense2 days ago
Foreign Troops withdrawal at a faster pace from Afghanistan
Defense3 days ago
“African Lion 2021”: More than military Show between the US and Morocco
Defense3 days ago
What position would Russia take in case of an armed conflict between China and US?
Europe3 days ago
American diplomacy’s comeback and Bulgaria’s institutional trench war
Russia3 days ago
Biden-Putin Geneva Summit: Even A Little More Than Nothing Means A Lot
Southeast Asia3 days ago
ASEAN Peace Initiative and the Myanmar Crisis: A Failed Attempt?
Energy2 days ago
Nuclear Energy is not Dead! The Drivers Underpinning the Ongoing Nuclear Renaissance
Intelligence2 days ago
Towards Increasingly Complex Multipolarity: Scenario for the Future